ArticleCancers2022

Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.

Jiri Minarik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.